In developing countries, fewer women have access to multidisciplinary congenital heart disease and reproductive programs staffed by experts. We report pregnancy outcomes of a multidisciplinary healthcare strategy utilizing an in-hospital teamwork approach in Vietnam.
Methods
This retrospective cohort study included pregnant women with unrepaired congenital heart disease managed at a referral cardiovascular center.
Results
Undiagnosed congenital heart disease before pregnancy, a lack of pre-pregnancy cardiology counseling, and modified World Health Organization class III/IV were common. Under the multispecialty healthcare strategy, although the rate of maternal death was 8.2% in the modified World Health Organization class IV group, no deaths occurred in any other group. Fetal/neonatal complications occurred in 54% of pregnancies, and 49.4% of neonates survived. Poor pregnancy outcomes were associated with admission during the first/seconde trimester for fetus/neonates, third trimester for mother, modified World Health Organization class III/IV, cyanosis, and heart failure.
Conclusion
The outcomes of pregnant women with unrepaired congenital heart disease were poor but seemed to improve with a multidisciplinary in-hospital healthcare teamwork strategy.
ZimmermanMSSmithAGCSableCA, et al.Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Child & Adolescent Health2020; 4: 185–200.
2.
van der BomTBoumaBJMeijboomFJ, et al.The prevalence of adult congenital heart disease, results from a systematic review and evidence based calculation. Am Heart J2012; 164: 568–575.
WuMHLuCWChenHC, et al.Adult Congenital Heart Disease in a Nationwide Population 2000–2014: Epidemiological Trends, Arrhythmia, and Standardized Mortality Ratio. J Am Heart Assoc2018; 7, DOI: 10.1161/jaha.117.007907.
5.
ThornburgKLJacobsonSLGiraudGD, et al.Hemodynamic changes in pregnancy. Semin Perinatol2000; 24: 11–14.
6.
SilversidesCKGrewalJMasonJ, et al.Pregnancy outcomes in women with heart disease: the CARPREG II study. J Am Coll Cardiol2018; 71: 2419–2430.
7.
RamageKGrabowskaKSilversidesC, et al.Association of adult congenital heart disease with pregnancy, maternal, and neonatal outcomes. JAMA Network Open2019; 2: e193667.
8.
StoutKKDanielsCJAboulhosnJA, et al.2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation2019; 139: e698–e800.
9.
BaumgartnerHDe BackerJBabu-NarayanSV, et al.2020 ESC guidelines for the management of adult congenital heart disease: the task force for the management of adult congenital heart disease of the European Society of Cardiology (ESC) endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), international society for adult congenital heart disease (ISACHD). Eur Heart J2020: 563–645. DOI: 10.1093/eurheartj/ehaa554.
10.
TaylorCMcCanceDRChappellL, et al.Implementation of guidelines for multidisciplinary team management of pregnancy in women with pre-existing diabetes or cardiac conditions: results from a UK national survey. BMC Pregnancy Childbirth2017; 17: 34.
11.
EdwinFZühlkeLFaroukH, et al.Status and challenges of care in Africa for adults with congenital heart defects. World J Pediatr Congenit Heart Surg2017; 8: 495–501.
12.
ZühlkeLLawrensonJComitisG, et al.Congenital heart disease in low- and lower-middle-income countries: current status and new opportunities. Curr Cardiol Rep2019; 21: 163.
13.
AroraNKausarHJanaN, et al.Congenital heart disease in pregnancy in a low-income country. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics2015; 128: 30–32.
14.
HuJYeYLuA, et al.Pregnancy outcomes in patients with heart disease in China. Am J Cardiol2020; 125: 1718–1724.
15.
DiezJR. Vietnam 30 years after Doi Moi: achievements and challenges. Zeitschrift für Wirtschaftsgeographie2016; 60: 121–133.
16.
Nguyen ManhTBui VanNLe ThiH, et al.Pregnancy with heart disease: maternal outcomes and risk factors for fetal growth restriction. Int J Environ Res Public Health2019; 16, DOI: 10.3390/ijerph16122075.
17.
PhucVMTinDNGiangDTC. Challenges in the management of congenital heart disease in Vietnam: a single center experience. Ann Pediatr Cardiol2015; 8: 44–46.
18.
Regitz-ZagrosekVRoos-HesselinkJWBauersachsJ, et al.2018 ESC guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J2018; 39: 3165–3241.
19.
LaopaiboonMLumbiganonPIntarutN, et al.Advanced maternal age and pregnancy outcomes: a multicountry assessment. BJOG: An International Journal of Obstetrics and Gynaecology2014; 121: 49–56.
20.
BrownMAMageeLAKennyLC, et al.Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension (Dallas, Tex: 1979)2018; 72: 24–43.
21.
GalièNHumbertMVachieryJ-L, et al.2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J2015; 37: 67–119.
22.
LiuHHuangTZhaoW, et al.Pregnancy outcomes and relative risk factors among Chinese women with congenital heart disease. International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics2013; 120: 245–248.
23.
LiuYChenSZühlkeL, et al.Global prevalence of congenital heart disease in school-age children: a meta-analysis and systematic review. BMC Cardiovasc Disord2020; 20: 88.
24.
Roos-HesselinkJBarisLJohnsonM, et al.Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry of Pregnancy and Cardiac disease (ROPAC). Eur Heart J2019; 40: 3848–3855.
25.
ChuRChenWSongG, et al.Predicting the risk of adverse events in pregnant women with congenital heart disease. J Am Heart Assoc2020; 9: e016371.
26.
CauldwellMSteerPJSwanL, et al.Pre-pregnancy counseling for women with heart disease: a prospective study. Int J Cardiol2017; 240: 374–378.
27.
SongYBParkSWKimJH, et al.Outcomes of pregnancy in women with congenital heart disease: a single center experience in Korea. J Korean Med Sci2008; 23: 808–813.
28.
DrenthenWPieperPGRoos-HesselinkJW, et al.Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol2007; 49: 2303–2311.
29.
LadouceurMBenoitLRadojevicJ, et al.Pregnancy outcomes in patients with pulmonary arterial hypertension associated with congenital heart disease. Heart (British Cardiac Society)2017; 103: 287–292.
30.
FurenäsEErikssonPWennerholmUB, et al.Effect of maternal age and cardiac disease severity on outcome of pregnancy in women with congenital heart disease. Int J Cardiol2017; 243: 197–203.
31.
HrycykJKaemmererHNagdymanN, et al.Mode of delivery and pregnancy outcome in women with congenital heart disease. PloS one2016; 11: e0167820.
32.
BonninMMercierFJSitbonO, et al.Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology2005; 102: 1133–1137. discussion 1135A-1136A.
33.
AsfourVMurphyMOAttiaR. Is vaginal delivery or caesarean section the safer mode of delivery in patients with adult congenital heart disease?Interact Cardiovasc Thorac Surg2013; 17: 144–150.
34.
NtiloudiDZegkosTBazmpaniMA, et al.Pregnancy outcome in women with congenital heart disease: a single-center experience. Hellenic Journal of Cardiology: HJC = Hellenike Kardiologike Epitheorese2018; 59: 155–159.
35.
DrenthenWBoersmaEBalciA, et al.Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J2010; 31: 2124–2132.
36.
DaruJZamoraJFernández-FélixBM, et al.Risk of maternal mortality in women with severe anaemia during pregnancy and post partum: a multilevel analysis. Lancet Glob Health2018; 6: e548–e554.
37.
RukuniRBhattacharyaSMurphyMF, et al.Maternal and neonatal outcomes of antenatal anemia in a Scottish population: a retrospective cohort study. Acta Obstet Gynecol Scand2016; 95: 555–564.
38.
DimopoulosKDillerGPGiannakoulasG, et al.Anemia in adults with congenital heart disease relates to adverse outcome. J Am Coll Cardiol2009; 54: 2093–2100.
39.
LiQDimopoulosKLiuT, et al.Peripartum outcomes in a large population of women with pulmonary arterial hypertension associated with congenital heart disease. Eur J Prev Cardiol2019; 26: 1067–1076.
40.
IshidaSUchiyamaAImaiK, et al.Brain-type natriuretic peptide level in pregnant women with congenital heart disease predicts SGA offspring. Pediatrics International: Official Journal of the Japan Pediatric Society2019; 61: 1221–1226.
41.
KampmanMABalciAvan VeldhuisenDJ, et al.N-terminal pro-B-type natriuretic peptide predicts cardiovascular complications in pregnant women with congenital heart disease. Eur Heart J2014; 35: 708–715.
42.
SuwanrathCThongphanangPPinjaroenS, et al.Validation of modified world health organization classification for pregnant women with heart disease in a tertiary care center in southern Thailand. Int J Womens Health2018; 10: 47–53.
43.
EasterSRValenteAMEconomyKE. Creating a multidisciplinary pregnancy heart team. Curr Treat Options Cardiovasc Med2020; 22: 3.
44.
YuliyantiSUtariniATrisnantoroL. A protocol study of participatory action research: integrated care pathway for pregnant women with heart disease in Indonesia. BMC Health Serv Res2020; 20: 932.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
